{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:46:07Z","timestamp":1787237167266,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":7231,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1157\/13094248","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T08:54:52Z","timestamp":1163667292000},"page":"428-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["El tratamiento con triptorelina en las ni\u00f1as con pubertad precoz central provoca incremento del \u00edndice de masa corporal"],"prefix":"10.1016","volume":"65","author":[{"given":"M.aJ.","family":"Mart\u00edn D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Soriano Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.aT.","family":"Mu\u00f1oz Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pozo Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Argente Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1157\/13094248_bib1","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1542\/peds.104.4.936","article-title":"Reexamination of the age limit for defining when puberty is precocious in girls in the United States: Implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society","volume":"104","author":"Kaplowitz","year":"1999","journal-title":"Pediatrics"},{"key":"10.1157\/13094248_bib2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1542\/peds.107.6.1493","article-title":"Age of puberty among girls and the diagnosis of precocious puberty","volume":"107","author":"Lee","year":"2001","journal-title":"Pediatrics"},{"key":"10.1157\/13094248_bib3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/er.2002-0019","article-title":"The timing of normal puberty and the age limits of sexual precocity: Variations around the world, secular trends, and changes after migration","volume":"24","author":"Parent","year":"2003","journal-title":"Endocr Rev"},{"issue":"Suppl 1","key":"10.1157\/13094248_bib4","first-page":"695","article-title":"Etiology and age incidence of precocious puberty in girls: A multicentric study","volume":"13","author":"Cisternino","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1157\/13094248_bib5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1515\/jpem-2001-s211","article-title":"Optimal therapy of pubertal disorders in precocious\/early puberty","volume":"14","author":"Tato","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1157\/13094248_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0022-3476(83)80648-9","article-title":"How many cases of true precocious puberty in girls are idiopathic?","volume":"102","author":"Cacciari","year":"1983","journal-title":"J Pediatr"},{"issue":"Suppl 1","key":"10.1157\/13094248_bib7","first-page":"703","article-title":"Central precocious puberty: Clinical and imaging aspects","volume":"13","author":"Cassio","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1157\/13094248_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1067\/S0022-3476(03)00328-7","article-title":"Selecting girls with precocious puberty for brain imaging: Validation of European evidence-based diagnosis rule","volume":"143","author":"Chalumeau","year":"2003","journal-title":"J Pediatr"},{"key":"10.1157\/13094248_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1542\/peds.109.1.139","article-title":"Precocious puberty in girls and the risk of a central nervous system abnormality: The elusive search for diagnostic certainty","volume":"109","author":"Kaplowitz","year":"2002","journal-title":"Pediatrics"},{"key":"10.1157\/13094248_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1210\/jcem.84.2.5431","article-title":"Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone","volume":"84","author":"Pasquino","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1157\/13094248_bib11","first-page":"835","article-title":"Adolescent girls with idiopathic central precocious puberty: Typical character traits","volume":"13","author":"Officioso","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1157\/13094248_bib12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1651-2227.1997.tb08602.x","article-title":"Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long-acting triptorelin therapy","volume":"86","author":"Xhrouet-Heinrichs","year":"1997","journal-title":"Acta Paediatr"},{"key":"10.1157\/13094248_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/jcem-52-2-370","article-title":"Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: A potential new treatment for idiopathic precocious puberty","volume":"52","author":"Crowley","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13094248_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(81)91155-7","article-title":"D-TRP5-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty","volume":"2","author":"Laron","year":"1981","journal-title":"Lancet"},{"key":"10.1157\/13094248_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2265.2002.01393.x","article-title":"Height prognosis in girls with central precocious puberty treated with GnRH analogues","volume":"56","author":"Kelnar","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1157\/13094248_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2265.2002.01488.x","article-title":"Factors predicting adult height in girls with idiopathic central precocious puberty: Implications for treatment","volume":"56","author":"Adan","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1157\/13094248_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1530\/eje.0.1410140","article-title":"Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty","volume":"141","author":"Arrigo","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1157\/13094248_bib18","first-page":"415","article-title":"Adult height in girls with idiopathic true precocious puberty","volume":"79","author":"Brauner","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13094248_bib19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2265.2004.02146.x","article-title":"Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty","volume":"61","author":"Paterson","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1157\/13094248_bib20","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/jc.2004-1863","article-title":"Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: Evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty","volume":"90","author":"Tanaka","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13094248_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jcem.84.1.5409","article-title":"Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: Long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty","volume":"84","author":"Feuillan","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13094248_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/eje.0.1500533","article-title":"Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty","volume":"150","author":"Arrigo","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1157\/13094248_bib23","first-page":"890","article-title":"Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists","volume":"75","author":"Jay","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13094248_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/adc.75.4.292","article-title":"Final height in central precocious puberty after long term treatment with a slow release GnRH agonist","volume":"75","author":"Oostdijk","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1157\/13094248_bib25","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/jcem.86.10.7915","article-title":"Increased final height in precocious puberty after long-term treatment with LHRH agonists: The National Institutes of Health experience","volume":"86","author":"Klein","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13094248_bib26","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jcem.84.6.5647","article-title":"Final height after long-term treatment with triptorelin slow release for central precocious puberty: Importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty","volume":"84","author":"Carel","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13094248_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/jc.2002-021999","article-title":"Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty","volume":"89","author":"Weise","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13094248_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1067\/mpd.2000.109201","article-title":"Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?","volume":"137","author":"Leger","year":"2000","journal-title":"J Pediatr"},{"key":"10.1157\/13094248_bib29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0022-3476(95)70221-0","article-title":"Bayley-Pinneau method of height prediction in girls with central precocious puberty: Correlation with adult height","volume":"126","author":"Bar","year":"1995","journal-title":"J Pediatr"},{"key":"10.1157\/13094248_bib30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1651-2227.1994.tb12984.x","article-title":"Final height in girls with central precocious puberty: Comparison of two different luteinizing hormone-releasing hormone agonist treatments","volume":"83","author":"Antoniazzi","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1157\/13094248_bib31","first-page":"54","article-title":"Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method","volume":"47","author":"Kauli","year":"1997","journal-title":"Horm Res"},{"key":"10.1157\/13094248_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humupd\/dmh012","article-title":"Precocious puberty and statural growth","volume":"10","author":"Carel","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1157\/13094248_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1542\/peds.109.1.61","article-title":"Central precocious puberty in girls: An evidence-based diagnosis tree to predict central nervous system abnormalities","volume":"109","author":"Chalumeau","year":"2002","journal-title":"Pediatrics"},{"key":"10.1157\/13094248_bib34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/adc.88.5.414","article-title":"Cranial MRI scans are indicated in all girls with central precocious puberty","volume":"88","author":"Ng","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1157\/13094248_bib35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00008480-200008000-00020","article-title":"Management of central isosexual precocity: Diagnosis, treatment, outcome","volume":"12","author":"Lebrethon","year":"2000","journal-title":"Curr Opin Pediatr"},{"key":"10.1157\/13094248_bib36","first-page":"4480","article-title":"Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty","volume":"84","author":"Palmert","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13094248_bib37","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1210\/jc.2002-021154","article-title":"Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation","volume":"88","author":"Antoniazzi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1157\/13094248_bib38","first-page":"791","article-title":"Precocious puberty and body composition: Effects of GnRH analog treatment","volume":"13","author":"Chiumello","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1157\/13094248_bib39","first-page":"773","article-title":"End results in central precocious puberty with GnRH analog treatment: The data of the Italian Study Group for Physiopathology of Puberty","volume":"13","author":"Antoniazzi","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1157\/13094248_bib40","first-page":"4583","article-title":"Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: Final height, body proportions, body composition, bone mineral density, and reproductive function","volume":"84","author":"Heger","year":"1999","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403306702235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403306702235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:20:57Z","timestamp":1787106057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403306702235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1695403306702235"],"URL":"https:\/\/doi.org\/10.1157\/13094248","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"El tratamiento con triptorelina en las ni\u00f1as con pubertad precoz central provoca incremento del \u00edndice de masa corporal","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1157\/13094248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}